Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target.

MLA

Khan, Maliha, et al. “Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target.” Frontiers in Immunology, vol. 8, Jan. 2018, p. 1975. EBSCOhost, https://doi.org/10.3389/fimmu.2017.01975.

APA

Khan, M., Carmona, S., Sukhumalchandra, P., Roszik, J., Philips, A., Perakis, A. A., Kerros, C., Zhang, M., Qiao, N., John, L. S. S., Zope, M., Goldberg, J., Qazilbash, M., Jakher, H., Clise-Dwyer, K., Qiu, Y., Mittendorf, E. A., Molldrem, J. J., Kornblau, S. M., & Alatrash, G. (2018). Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target. Frontiers in Immunology, 8, 1975. https://doi.org/10.3389/fimmu.2017.01975

Chicago

Khan, Maliha, Selena Carmona, Pariya Sukhumalchandra, Jason Roszik, Anne Philips, Alexander A Perakis, Celine Kerros, et al. 2018. “Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target.” Frontiers in Immunology 8 (January): 1975. doi:10.3389/fimmu.2017.01975.